Vitamin Shoppe Inc (NYSE:VSI) shares shot up 5.6% during mid-day trading on Monday . The company traded as high as $7.60 and last traded at $7.60. 549,785 shares traded hands during mid-day trading, a decline of 9% from the average session volume of 604,783 shares. The stock had previously closed at $7.20.
A number of brokerages have issued reports on VSI. ValuEngine downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Friday, June 1st. Morgan Stanley reduced their price objective on Vitamin Shoppe from $4.00 to $3.75 and set an “equal weight” rating for the company in a research note on Wednesday, February 28th. Finally, Zacks Investment Research upgraded Vitamin Shoppe from a “sell” rating to a “hold” rating in a research note on Wednesday, May 16th. Four analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. Vitamin Shoppe currently has an average rating of “Hold” and an average price target of $4.95.
The company has a market cap of $184.16 million, a PE ratio of 18.97 and a beta of 0.51. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.88 and a quick ratio of 0.44.
Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings data on Wednesday, May 9th. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.10. The firm had revenue of $295.96 million during the quarter, compared to the consensus estimate of $293.44 million. Vitamin Shoppe had a positive return on equity of 1.28% and a negative net margin of 22.80%. equities analysts forecast that Vitamin Shoppe Inc will post -0.21 earnings per share for the current year.
In other news, Director Guillermo Marmol purchased 20,000 shares of the business’s stock in a transaction dated Friday, May 25th. The stock was bought at an average price of $5.15 per share, for a total transaction of $103,000.00. Following the purchase, the director now owns 29,631 shares of the company’s stock, valued at $152,599.65. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Alex Smith purchased 12,666 shares of the business’s stock in a transaction dated Tuesday, May 29th. The shares were purchased at an average price of $5.24 per share, with a total value of $66,369.84. Following the purchase, the chairman now directly owns 19,118 shares in the company, valued at approximately $100,178.32. The disclosure for this purchase can be found here. Insiders have bought a total of 190,053 shares of company stock valued at $805,158 in the last quarter. 18.50% of the stock is owned by corporate insiders.
Hedge funds have recently bought and sold shares of the company. Schwab Charles Investment Management Inc. grew its stake in shares of Vitamin Shoppe by 106.0% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 667,112 shares of the specialty retailer’s stock worth $2,936,000 after acquiring an additional 343,326 shares during the period. Lazard Asset Management LLC bought a new position in shares of Vitamin Shoppe during the 4th quarter worth $115,000. Stone Ridge Asset Management LLC bought a new position in shares of Vitamin Shoppe during the 4th quarter worth $285,000. OppenheimerFunds Inc. grew its stake in shares of Vitamin Shoppe by 27.8% during the 4th quarter. OppenheimerFunds Inc. now owns 194,339 shares of the specialty retailer’s stock worth $855,000 after acquiring an additional 42,269 shares during the period. Finally, Tamarack Advisers LP bought a new position in shares of Vitamin Shoppe during the 1st quarter worth $4,870,000. Institutional investors own 88.46% of the company’s stock.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.